Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes

Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes

US Patent 7642259 · Granted Jan 5, 2010

Estimated economic value: $11,018,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fused tricyclic compounds useful as anticancer agents2025
Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer2023
[1,2,4]triazolo[4,3-b]pyridazines for use in the treatment of proliferative dise2022
Pyridine and pyrimidine derivatives2022
Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer2021
Composition and dressing with nitric oxide2020
Composition and dressing with nitric oxide2020
[1,2,4]triazolo[4,3-B]pyridazines for use in the treatment of proliferative dise2020
Chemical compounds2020
Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer2019
[1,2,4]triazolo[4,3-B]pyridazines for use in the treatment of proliferative dise2019
Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer2019